within Pharmacolibrary.Drugs.ATC.A;

model A12CC10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.04,
    Cl             = 6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0006666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium oxide is an inorganic compound commonly used as a mineral supplement to prevent or treat low levels of magnesium in the body. It can also be used as an antacid to relieve heartburn, sour stomach, or acid indigestion, and as a laxative for short-term, rapid emptying of the bowel. It is an approved medication, available over-the-counter in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult healthy individuals after typical oral administration, as there are no published detailed compartmental PK models for magnesium oxide using this ATC code. Values are based on published general information on magnesium absorption kinetics.</p><h4>References</h4><ol><li><p>Lindberg, JS, et al., &amp; Pak, CY (1990). Magnesium bioavailability from magnesium citrate and magnesium oxide. <i>Journal of the American College of Nutrition</i> 9(1) 48–55. DOI:<a href=&quot;https://doi.org/10.1080/07315724.1990.10720349&quot;>10.1080/07315724.1990.10720349</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2407766/&quot;>https://pubmed.ncbi.nlm.nih.gov/2407766</a></p></li><li><p>Kashihara, Y, et al., &amp; Ieiri, I (2019). Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation. <i>European journal of clinical pharmacology</i> 75(3) 351–361. DOI:<a href=&quot;https://doi.org/10.1007/s00228-018-2568-4&quot;>10.1007/s00228-018-2568-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30382297/&quot;>https://pubmed.ncbi.nlm.nih.gov/30382297</a></p></li><li><p>Werner, T, et al., &amp; Cibulka, M (2019). Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects. <i>Magnesium research</i> 32(3) 63–71. DOI:<a href=&quot;https://doi.org/10.1684/mrh.2019.0457&quot;>10.1684/mrh.2019.0457</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32162607/&quot;>https://pubmed.ncbi.nlm.nih.gov/32162607</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A12CC10;
